COMMENTARY OUTCOME OF PERMANENT PACEMAKER IMPLANTATION IN TRANSCATHETER
OR SURGICAL AORTIC VALVE REPLACEMENT: A STILL UNSOLVED PROBLEM.
Despite advances in technologies and clinical experience, conduction
disorders, after TAVR or SAVR, represent the weak point of these
procedures, requiring permanent pacemaker implantation (PPI) till 37.7%
of patients in TAVR recipients. The role of PPI in TAVR and SAVR remains
controversial in mid- and long-term outcomes. Indeed, many studies have
been published with contradictory results, leaving doubts rather than